Check if you have access via personal or institutional login Written as a response to the increasing utilization of minimally invasive procedures in children, this state-of-the-art book provides a ...

一、既要避免过度诊断，又要避免诊断不足，这时就要用好“激发试验”首先，我们为何会编写《支气管激发试验临床应用中国专家共识》（点击前方蓝字可跳转阅读）？目前轻度、部分中度以及不典型哮喘的主要诊断挑战在于“诊断”，重度哮喘更重要的是“治疗”，轻度及不典型 ...

Diagnosing antibody-mediated rejection in liver transplant recipients is hindered by a lack of biomarkers and co-occurrence ...

EMA approves Dupixent to treat eosinophilic esophagitis in children as young as one year: Paris Thursday, November 7, 2024, 14:00 Hrs [IST] The European Medicines Agency has appro ...

Dupixent approved in the EU as the first and only medicine for young children with eosinophilic esophagitisApproval based on phase 3 data showing ...

Check if you have access via personal or institutional login This step-by-step practical diagnostic guide takes a fresh look at inflammatory skin disorders by focusing on the practicalities of ...

Approval based on Phase 3 data showing significantly more children aged 1 to 11 years on Dupixent achieved histological disease remission at 16 ...

Intra-amniotic infection (IAI), or chorioamnionitis, complicates up to 10% of all pregnancies and up to 2% of labors at term. There is a significant risk of complications for the mother and the ...

Eosinophilic gastroenteritis (EGE) is characterized by dense eosinophilic inflammation of one or several digestive tract sections. The symptoms include abdominal pain, weight loss, vomiting and ...

The team also indicated that cancer PDOs effectively recapitulate the histopathologic characterization of parental tumors. Additionally, organoids do exhibit a degree of preservation of the genomic ...

Sepsis is a life threatening illness that develops when an existing infection triggers an extreme immune system response in your body. When you experience an infection, your immune system releases ...

Dupixent approved in the EU as the first and only medicine for young children with eosinophilic esophagitis Approval based on phase 3 data showing significantly more children aged one to 11 years on ...